Screening for renal disease - What can be learned from the Okinawa experience

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 839-843

  Iseki, Kunitoshi ^a  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Chronic kidney disease; End stage renal disease; Hypertension; Proteinuria; Screening

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

COMMUNITY CARE; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; DISEASE REGISTRY; EARLY DIAGNOSIS; EDITORIAL; EXERCISE; HEALTH CARE COST; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; JAPAN; KIDNEY DISEASE; KIDNEY FAILURE; LIFESTYLE; MASS SCREENING; METABOLIC SYNDROME X; OBESITY; PREDICTION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SCREENING TEST;

CHRONIC DISEASE; COST-BENEFIT ANALYSIS; HEALTH PROMOTION; HUMANS; JAPAN; KIDNEY DISEASES; REGISTRIES;

EID: 33645322381     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl026     Document Type: Editorial

References (46)

1. Wakai K, Nakai S, Kikuchi K et al. Trends in incidence of end-stage renal disease in Japan, 1983-2000: Age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant 2004; 16: 2044-2052
2. US Renal Data System. Excerpts from the USRDS 2001 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2001; 38 [Suppl 3]: S1-S248
3. Lysaght MJ. Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol 2002; 13 [Suppl 1]: S37-S40
4. Usami T, Koyama K, Takeuchi O, Morozumi K, Kimura G. Regional variation in the incidence of end-stage renal failure in Japan. JAMA 2000; 284: 622-624
5. Wada A, Kitaoka T, Nakai S et al. The current state of chronic dialysis treatment in Japan (as of December 31, 2003). J Jpn Soc Dial Ther 2005; 38: 1-16
6. Iseki K. Screening and prevention of renal disease: Large population study in Okinawa, Japan. Nephrology 1998; 4: S86-S89
7. Iseki K. The Okinawa screening program. J Am Soc Nephrol 2003; 14 [Suppl 2]: S127-S130
8. Iseki K. Factors influencing development of end-stage renal disease. Clin Exp Nephrol 2005; 9; 5-14
9. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805
10. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997; 51: 850-854
11. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468-1474
12. Iseki K, Ikemiya Y, Iseki C, Takishita S. Hematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant 2003; 18: 899-905
13. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 2003; 41: 1341-1345
14. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
15. Iseki K, Ikemiya Y, Kinjo K, Iseki C, Takishita S. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in a screened cohort. Clin Exp Nephrol 2004; 8: 250-256
16. Iseki K, Ikemiya Y, Inoue T et al. Significance of hyperuricemia as a risk factor of developing ESRD in a screened cohort. Am J Kidney Dis 2004; 44: 642-650
17. Iseki K, Kinjo K, Iseki C, Takishita S. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004; 44: 806-814
18. Iseki K, Ikemiya Y, Fukiyama K. Serum cholesterol and risk of end-stage renal disease in a cohort of mass screening. Clin Exp Nephrol 1998; 2: 18-24
19. Iseki K, Wakugami K, Maehara A, Tozawa M, Muratani H, Fukiyama K. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger. Am J Kidney Dis 2001; 38: 1235-1239
20. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002; 62: 956-962
21. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. riglyceride, but not total cholesterol or low-density lipoprotein cholesterol, levels predicts development of proteinuria. Kidney Int 2002; 62: 1743-1749
22. Iseki K, Tozawa M, Ikemiya Y, Kinjo K, Iseki C, Takishita S. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort. Clin Exp Nephrol 2005; 9; 46-52
23. Iseki K, Miyasato F, Uehara H et al. Outcome study of renal biopsy patients in Okinawa, Japan. Kidney Int 2004; 66: 914-919
24. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374
25. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169
26. Yamagata K, Takahashi H, Suzuki S et al. Age distribution and yearly changes in the incidence of ESRD in Japan. Am J Kidney Dis 2004; 43: 433-443
27. Yamagata K, Yamagata Y, Kobayashi M, Koyama A. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 1996; 45: 281-288
28. Murakami M, Yamamoto H, Ueda Y, Murakami K, Yamauchi K. Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo. Pediatr Nephrol 1991; 5: 50-53
29. Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 1993; 43: 404-409
30. Iseki K, Miyasato F, Oura T, Uehara H, Nishime K, Fukiyama K. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994; 23: 547-554
31. Iseki K, Tozawa M, Iseki C, Takishita S, Ogawa Y. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int 2002; 61: 668-675
32. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, Classification, and Stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S170-S212
33. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174
34. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria. The Framingham study. Am Heart J 1984; 108: 1347-1352
35. Hillege HL, Fidler V, Diercks GFH et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782
36. Muntner P, He J, Hamm L et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753
37. Iseki K, Kimura Y, Wakugami K et al. Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res 2000; 23: 143-149
38. Rossert JA, Wauters JP. Recommendations for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant 2002; 17 [Suppl 1]: 19-28
39. Dimitrov BD, Perna A, Ruggenenti P, Remuzzi G. Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level. Kidney Int 2003; 63: 1924-1933
40. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults. A cost-effectiveness analysis. JAMA 2003; 290: 3101-3114
41. Tozawa M, Oshiro S, Iseki C et al. Multiple risk factor clustering of hypertension in a screened cohort. J Hypertens 2000; 18: 1379-1385
42. Tozawa M, Oshiro S, Iseki C et al. Family history of hypertension and blood pressure in a screened cohort. Hypertens Res 2001; 24: 93-98
43. Sunagawa H, Iseki K, Nishime K et al. Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 1996; 74: 361-366
44. Iseki K for the Okinawa Dialysis Study (OKIDS) Group. Analysis of referral pattern and survival in chronic dialysis patients in Okinawa, Japan (1993-1997). Clin Exp Nephrol 2002; 6: 43-48
45. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001; 59: 1498-1509
46. McClellan WM, Ramirez SPB, Jurkovitz C. Screening for chronic kidney disease: Unresolved issues. J Am Soc Nephrol 2003; 14: S81-S87